Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 21, 2018 ) POC blood glucose monitoring devices are portable, near-patient devices that allow the immediate detection of glucose levels in a patient and facilitate rapid treatment solutions if the need arises. These devices consist of minimum operator interaction and are non-invasive in nature with efficient data management and connectivity tools. Publisher's analysts forecast the global POC blood glucose monitoring devices market to grow at a USD 2,036.4 million during the period 2018-2022.
Covered in this report The report covers the present scenario and the growth prospects of the global POC blood glucose monitoring devices market for 2018-2022. To calculate the market size, the report considers the revenue generated from the POC blood glucose monitoring devices.
The market is divided into the following segments based on geography: -Americas -APAC -EMEA
FREE | Request Sample Copy is Available at http://www.reportsweb.com/inquiry&RW00011564789/sample
Key vendors: -Abbott -ARKRAY -Ascensia Diabetes Care -Danaher -F. Hoffmann-La Roche -Johnson & Johnson
Market Driver: -Public and private initiatives to reduce diabetic cases -For a full, detailed list, view our report
Market Challenge: -High cost associated with diabetes management -For a full, detailed list, view our report
Market Trend: -Paradigm shift towards non-invasive products -For a full, detailed list, view our report
Complete Report is Available at http://www.reportsweb.com/global-poc-blood-glucose-monitoring-devices-market-2018-2022
Key questions answered in this report: -What will the market size be in 2022 and what will the growth rate be- -What are the key market trends- -What is driving this market- -What are the challenges to market growth- -Who are the key vendors in this market space-
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|